Page last updated: 2024-11-03

ag 1879 and Leukemia, Myeloid, Acute

ag 1879 has been researched along with Leukemia, Myeloid, Acute in 2 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Williams, NK1
Lucet, IS1
Klinken, SP1
Ingley, E1
Rossjohn, J1
Boehrer, S1
Galluzzi, L1
Lainey, E1
Bouteloup, C1
Tailler, M1
Harper, F1
Pierron, G1
Adès, L1
Thépot, S1
Sébert, M1
Gardin, C1
de Botton, S1
Fenaux, P1
Kroemer, G1

Other Studies

2 other studies available for ag 1879 and Leukemia, Myeloid, Acute

ArticleYear
Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state.
    The Journal of biological chemistry, 2009, Jan-02, Volume: 284, Issue:1

    Topics: Adenylyl Imidodiphosphate; Animals; Apoenzymes; B-Lymphocytes; Catalytic Domain; Crystallography, X-

2009
Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia.
    Cell cycle (Georgetown, Tex.), 2011, Sep-15, Volume: 10, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Biomarkers, Tumor; Enzyme Acti

2011